Salvage Re-Irradiation after Complex Treatment in Childhood Leptomeningeal Metastatic Medulloblastoma-Clinical Case withLiterature Review

Authors

  • Lena Marinova Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Vaska Vasileva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Nikolay Kahchiev Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Nadezhda Tsvetkova Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Katia Sergieva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author

DOI:

https://doi.org/10.47363/JPRRR/2026(8)193

Keywords:

Leptomeningeal Metastases, High-Risk Medulloblastoma, Salvage Re-Radiotherapy, Leukoencephalopathy, Subacute Radiation Neurotoxicity

Abstract

Leptomeningeal metastases diagnosed in a child with high-risk medulloblastoma immediately after surgery are very rare. The primary treatment is extremely complicated, namely the assessment of the duration of systemic and intraventricular chemo- and immunotherapy, as well as the timing of starting craniospinal radiotherapy. Even more complicated is the question “When in time, in what volume and with what cumulative doses should salvage re-radiotherapy be performed in a child with long-term observed leptomeningeal spread diagnosed immediately after the initial surgery?”. Based on a clinical case of a child with high-risk medulloblastoma and a literature review, we aim to answer the above questions.

Author Biographies

  • Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Vaska Vasileva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Nikolay Kahchiev, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Nadezhda Tsvetkova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Katia Sergieva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

Downloads

Published

2026-01-30